Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ripamonti

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Anti-Cancer Drug Design|December 1, 1995
Sequence-specific DNA interactions by novel alkylating anthracycline derivativesS Marchini, O Gonzalez Paz, M Ripamonti, et al.
European Journal of Biochemistry|January 2, 1989
The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cellsF P Conde, R Orlandi, S Canevari, et al.
Clinical Chemistry|January 1, 1983
Measurement of glucose in plasma by a differential pH techniqueM Luzzana, G Dossi, A Mosca, et al.
Journal of Proteome Research|March 30, 2007
Metabolic modulation induced by chronic hypoxia in rats using a comparative proteomic analysis of skeletal muscle tissueS De Palma, M Ripamonti, A Vigano, et al.
Cancer Research|March 31, 2001
Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agentC Geroni, M Ripamonti, C Arrigoni, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Anti-Cancer Drug Design|December 1, 1995
Sequence-specific DNA interactions by novel alkylating anthracycline derivativesS Marchini, O Gonzalez Paz, M Ripamonti, et al.
European Journal of Biochemistry|January 2, 1989
The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cellsF P Conde, R Orlandi, S Canevari, et al.
Clinical Chemistry|January 1, 1983
Measurement of glucose in plasma by a differential pH techniqueM Luzzana, G Dossi, A Mosca, et al.
Journal of Proteome Research|March 30, 2007
Metabolic modulation induced by chronic hypoxia in rats using a comparative proteomic analysis of skeletal muscle tissueS De Palma, M Ripamonti, A Vigano, et al.
Cancer Research|March 31, 2001
Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agentC Geroni, M Ripamonti, C Arrigoni, et al.
Pageof 7